|
WO2014194293A1
|
|
Improved methods for the selection of patients for pd-1 or b7-h4 targeted therapies, and combination therapies thereof
|
|
AU2014265142A1
|
|
Receptors for B7-H4
|
|
BR112015014063A2
|
|
human anti-b7-h4 antibodies and their uses.
|
|
AU2013227994A1
|
|
Compositions of PD-1 antagonists and methods of use
|
|
CN103608040A
|
|
Antibodies and other molecules that bind B7-H1 and PD-1
|
|
ZA201107552B
|
|
Composition of pd-1 antagonists and methods of use
|
|
WO2011066342A2
|
|
Simultaneous inhibition of pd-l1/pd-l2
|
|
EP2473523A2
|
|
Methods and compositions for the inhibition of transplant rejection
|
|
EP2662383A1
|
|
PD-I antagonists and methods for treating infectious disease
|
|
RS54233B1
|
|
Compositions of pd-1 antagonists and methods of use
|
|
UA106050C2
|
|
Normal;heading 1;heading 2;heading 3;COMPOSITION OF PD-1 ANTAGONIST AND A POTENTIATING AGENT FOR SIMULATING A T CELL RESPONSE
|
|
BRPI0917320A2
|
|
pd-1 antagonist compositions and methods of use
|
